Dow Up 1.13% Nasdaq Up 1.41%

Agenus Inc. (AGEN)

-NasdaqCM
2.98 Down 0.11(3.56%) 4:00PM EDT
Prev Close:3.09
Open:3.18
Bid:2.92 x 100
Ask:3.00 x 100
1y Target Est:7.00
Beta:1.82
Next Earnings Date:N/A
Day's Range:2.89 - 3.18
52wk Range:2.27 - 5.27
Volume:610,663
Avg Vol (3m):358,795
Market Cap:186.78M
P/E (ttm):N/A
EPS (ttm):-0.48
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
AGENDown 3.56%186.78M
ABPIUp 18.18%583.41K
DNDNDown 4.90%152.24M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):39.34
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.50
Quarterly EPS Est (Sep-14) :-0.15
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Agenus Inc., a biopharmaceutical company, is developing a portfolio of immuno-oncology candidates, including checkpoint modulators (CPMs), heat shock protein vaccines, and adjuvants. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback